These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 955238)

  • 21. Assessment of topical corticosteroid activity using the vasoconstriction assay in healthy volunteers.
    Görne RC; Greif C; Metzner U; Wigger-Alberti W; Elsner P
    Skin Pharmacol Physiol; 2007; 20(3):133-40. PubMed ID: 17191036
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bioequivalence (bioavailability) of generic topical corticosteroids.
    Jackson DB; Thompson C; McCormack JR; Guin JD
    J Am Acad Dermatol; 1989 May; 20(5 Pt 1):791-6. PubMed ID: 2715430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect on plasma cortisol level and urinary cortisol excretion, in healthy volunteers, after application of three different topical steroid ointments under occlusion.
    Scott M; Malmsten LA; Thelin I
    Acta Derm Venereol; 1981; 61(6):543-6. PubMed ID: 6177167
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vasoconstrictor activities of some novel synthetic steroids in alcoholic solution.
    Barry BW; Brace AR
    J Invest Dermatol; 1975 Jun; 64(6):418-22. PubMed ID: 1141715
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the efficacy of topical corticosteroids.
    Zaynoun ST; Kurban AK
    Br J Dermatol; 1974 Jan; 90(1):85-90. PubMed ID: 4811838
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparative blanching activities of proprietary diflucortolone valerate topical preparations.
    Coleman GL; Kanfer I; Haigh JM
    Dermatologica; 1978; 156(4):224-30. PubMed ID: 342295
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical trial comparing hydrocortisone 17-butyrate to betamethasone 17-valerate in a series of patients with eczematous skin diseases.
    Thormann J; Brodthagen H
    Dermatologica; 1976; 152 Suppl 1():209-14. PubMed ID: 782955
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Allergic reactions to topical corticosteroids or their vehicles.
    Fisher AA
    Cutis; 1983 Aug; 32(2):122, 129-32, 137. PubMed ID: 6225625
    [No Abstract]   [Full Text] [Related]  

  • 29. Optimization of bioavailability of topical steroids: penetration enhancers under occlusion.
    Barry BW; Southwell D; Woodford R
    J Invest Dermatol; 1984 Jan; 82(1):49-52. PubMed ID: 6690630
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A method for the assay of topical corticosteroids.
    Marks R; Pongsehirun D; Saylan T
    Br J Dermatol; 1973 Jan; 88(1):69-74. PubMed ID: 4686544
    [No Abstract]   [Full Text] [Related]  

  • 31. Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment.
    Hehir M; Du Vivier A; Eilon L; Danie MJ; Shenoy EV
    Clin Exp Dermatol; 1983 Mar; 8(2):143-51. PubMed ID: 6851236
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessing topical bioavailability and bioequivalence: a comparison of the in vitro permeation test and the vasoconstrictor assay.
    Lehman PA; Franz TJ
    Pharm Res; 2014 Dec; 31(12):3529-37. PubMed ID: 25005736
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Absorption of corticoid ointments].
    Winkler K
    Ann Dermatol Syphiligr (Paris); 1966; 93(3):265-70. PubMed ID: 5963643
    [No Abstract]   [Full Text] [Related]  

  • 34. Bioassay system for formulations of topically applied glucocorticosteroids.
    Stoughton RB
    Arch Dermatol; 1972 Dec; 106(6):825-7. PubMed ID: 4639246
    [No Abstract]   [Full Text] [Related]  

  • 35. Blanching activities of betamethasone formulations. The effect of dosage form on topical drug availability.
    Smith EW; Meyer E; Haigh JM
    Arzneimittelforschung; 1990 May; 40(5):618-21. PubMed ID: 2383308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Domoprednate (Stermonid), a topical D-homocorticosteroid, skin atrophy and telangiectasia. A double-blind, randomized comparison with hydrocortisone butyrate, betamethasone valerate, clobetasole propionate and placebo.
    Serup J; Holm P
    Dermatologica; 1985; 170(4):189-94. PubMed ID: 3888708
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The stability and blanching efficacy of betamethasone-17-valerate in emulsifying ointment.
    Ryatt KS; Feather JW; Mehta A; Dawson JB; Cotterill JA; Swallow R
    Br J Dermatol; 1982 Jul; 107(1):71-6. PubMed ID: 7104209
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A guide to topical corticosteroids.
    Goldman L
    Am Fam Physician; 1973 Sep; 8(3):167-70. PubMed ID: 4729714
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical studies of the action of a topical corticoid (betamethasone 17-benzoate) in a lipid vehicle with and without the addition of propylene glycol].
    Passetti ; bruni G
    Farmaco Prat; 1975 Jul; 30(7):340-6. PubMed ID: 1157914
    [No Abstract]   [Full Text] [Related]  

  • 40. Assay of topical corticosteroids. Efficacy of suppression of experimental Rhus dermatitis in humans.
    Kaidbey KH; Kligman AM
    Arch Dermatol; 1976 Jun; 112(6):808-13. PubMed ID: 133636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.